MedTrace Logo

Evaluating Whole Foods Supplementation on Cognition

NCT01672359 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2014-08-06

No results posted yet for this study

Summary

A six-month study which investigated the effect of Ginkgo Synergy® and Choline or OPC Synergy® and Catalyn® on cognitive and immune function markers and quality of life among healthy older adults with no history of significant cognitive deficits

Conditions

  • Sub-optimal Cognitive Function
  • Sub-optimal Immune Function

Interventions

DIETARY_SUPPLEMENT

Ginkgo Synergy® and Choline

3 tablets 2 times per day with breakfast and dinner over 6 months

DIETARY_SUPPLEMENT

OPC Synergy® and Catalyn

3 tablets 2 times per day with breakfast and dinner over 6 months

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Standard Process Inc.

    collaborator INDUSTRY

  • University of Miami

    lead OTHER

Principal Investigators

  • John Lewis, PhD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01672359 on ClinicalTrials.gov